DAHL ANDREW A 4
4 · Zivo Bioscience, Inc. · Filed Oct 25, 2021
Insider Transaction Report
Form 4
DAHL ANDREW A
President, CEO
Transactions
- Award
Nonstatutory Stock Option to Purchase Common Stock
2021-10-21+376,000→ 376,000 totalExercise: $5.50Exp: 2031-10-20→ Common Stock (376,000 underlying)
Footnotes (1)
- [F1]The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.